Vaccine success sees upbeat Mace revise tender price forecast

By Jordan Marshall2021-03-26T06:00:00

Firm says it is less pessimistic than it was three months ago

Mace has said the success of the UK’s vaccine rollout means it is less gloomy about 2021’s prospects that it was three months ago.

More than half of the UK’s adult population, 28 million, has received at least one dose of the vaccine with the country on track to meet its target of vaccinating its nine priority groups by its planned mid-April date.

Already registered? Login here

To continue enjoying Building.co.uk, sign up for free guest access

Existing subscriber? LOGIN

Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.

Limited access to building.co.uk
Breaking industry news as it happens
Breaking, daily and weekly e-newsletters

Get your free guest access SIGN UP TODAY

Subscribe now for unlimited access

Subscribe to Building today and you will benefit from:

Unlimited access to all stories including expert analysis and comment from industry leaders
Our league tables, cost models and economics data
Our online archive of over 10,000 articles
Building magazine digital editions
Building magazine print editions
Printed/digital supplements

Subscribe now for unlimited access.

View our subscription options and join our community